Search Results

Return to List
Results 1–9 of 9
Title Date

Hereditary Cancer Syndromes and Risk Assessment

Number 634

ABSTRACT A hereditary cancer syndrome is a genetic predisposition to certain types of cancer often with onset at an early age caused by inherited mutations in one or more genes Cases of cancer commonly encountered by obstetriciangynecologists or other obstetricgynecologic providersmdashsuch as bre...

June 2015

PDF Format

Salpingectomy for Ovarian Cancer Prevention

Number 620

ABSTRACT Ovarian cancer has the highest mortality rate out of all types of gynecologic cancer and is the fifth leading cause of cancer deaths among women Current attempts at screening for ovarian cancer have been unsuccessful and are associated with falsepositive test results that lead to unnecess...

January 2015

PDF Format

Gynecologic Concerns in Children and Adolescents With Cancer

Number 607

ABSTRACT Advancements in radiation therapy chemotherapy surgery and multimodal treatment have dramatically improved childhood cancer survival However cancer and its treatment may have immediate or delayed adverse effects on reproductive health Gynecologists should be prepared to manage gynecologic...

August 2014

PDF Format

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Number 606

ABSTRACT Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding emerg...

August 2014

PDF Format

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT Tamoxifen a nonsteroidal antiestrogen agent is widely used as adjunctive therapy for women with breast cancer and it has been approved by the US Food and Drug Administration for adjuvant treatment of breast cancer treatment of metastatic breast cancer and reduction in breast cancer incide...

June 2014

PDF Format

Oocyte Cryopreservation

Number 584

ABSTRACT In 2013 the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology published a joint document Mature Oocyte Cryopreservation A Guideline which addresses advances in techniques to freeze human eggs that have resulted in significant recent improvemen...

January 2014

PDF Format

Management of Vulvar Intraepithelial Neoplasia

Number 509

(Reaffirmed 2014)

ABSTRACT Vulvar intraepithelial neoplasia VIN is an increasingly common problem particularly among women in their 40s The term VIN is used to denote highgrade squamous lesions and is subdivided into usualtype VIN including warty basaloid and mixed VIN and differentiated VIN Usualtype VIN is common...

November 2011

PDF Format

The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer

Number 477

(Replaces No. 280, December 2002)

ABSTRACT Epithelial ovarian cancer is most commonly detected in an advanced stage when the overall 5year survival rate is 2030 Detection of earlystage ovarian cancer results in improved survival Currently there is no effective strategy for ovarian cancer screening Women with persistent and progres...

March 2011

PDF Format

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2014)

ABSTRACT Aromatase inhibitors appear to be effective as an adjuvant treatment for earlystage and latestage breast cancer Their role in chemoprevention of breast cancer in highrisk patients remains to be defined Side effects of aromatase inhibitors in postmenopausal women are due to estrogenlowerin...

August 2008

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998